
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
TearScience, a medical device company, pioneered technologies and leads innovation to vastly improve evaluation and treatment of meibomian gland dysfunction (MGD). A progressive, obstructive disease and root cause of dry eye, MGD is distinguished by loss of function and structure of tear oil glands. MGD affects approximately 86% of the 300 million dry eye sufferers worldwide and is highly prevalent in the general ophthalmic population. LipiView II and new LipiScan with Dynamic Meibomian ImagingTM (DMI) distinctively images meibomian gland structure. The Korb Meibomian Gland EvaluatorTM assists physicians to reproducibly assess gland function. LipiFlow uses Vectored Thermal PulseTM (VTP) technology to...
Medical device,optometric,ophthalmic solutions,and assessment & treatment for meibomian gland dysfunction/dry eye
Lipiflow operates in the Medical equipment manufacturing industry.
Lipiflow's revenue is 11m - 100m
Lipiflow has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.